-
Abbott's Upgraded TriClip Heart Valve System OK'd In Europe
Thursday, April 8, 2021 - 1:38pm | 284Read More...Abbott Laboratories (NYSE: ABT) won European approval for the latest generation of its TriClip system, a transcatheter-based repair device designed to stem leaks in the heart’s tricuspid valve. The tricuspid valve opens and closes a set of three flaps rather than two....
-
Edwards Lifesciences Gains 8% Following Positive Trial
Monday, April 4, 2016 - 7:36am | 280Read More...Shares of Edwards Lifesciences Corp (NYSE: EW) gained more than 8 percent early Monday morning after the company announced over the weekend results from a clinical study involving patients at intermediate risk for open-heart surgery. Edwards Lifesciences stated its data showed that patients at...
